西多福韦在腺病毒感染治疗中的应用  

Application of cidofovir in the treatment of adenovirus infection

在线阅读下载全文

作  者:王文博 胡静 刘媛 Wang Wenbo;Hu Jing;Liu Yuan(Department of Disease Control and Prevention,General Hospital of Western Theater Command,Chengdu 610083,China;Department of Clinical Laboratory,General Hospital of Western Theater Command,Chengdu 610083,China)

机构地区:[1]西部战区总医院疾病预防控制科,成都610083 [2]西部战区总医院检验科,成都610083

出  处:《中华实验和临床病毒学杂志》2024年第3期364-368,共5页Chinese Journal of Experimental and Clinical Virology

基  金:院管课题(2021-XZYG-B11);四川省科技厅重点研发项目(2019YFS0367)。

摘  要:腺病毒是一种双链DNA病毒,可引起呼吸道、胃肠道、眼睛、肾脏和其他器官感染,轻度腺病毒感染一般是自限性疾病,但部分患者进展为高热、呼吸困难、呼吸衰竭等严重感染或播散性感染疾病。目前尚无特异性抗腺病毒药物上市,本文总结了西多福韦在腺病毒感染临床治疗中的应用,从成人重症腺病毒感染、儿童腺病毒感染、器官移植患者感染及衍生物4个方面展开阐述。总体而言,西多福韦在治疗腺病毒重症感染中有一定作用,但多数研究样本量偏少且缺少前瞻性队列研究,今后开展相关临床研究时需重点考虑。另外基于西多福韦开发衍生化合物或寻找类似药物,降低其肾毒性,也是未来研究关注的重点。Adenovirus is a group of double-stranded DNA virus,which can cause infections of respiratory tract,gastrointestinal tract,eye,kidney and other organs.Adenovirus infection is generally self-limited disease,while in some patients progresses to high fever,dyspnea,respiratory failure and other serious infection or disseminated infection.At present,there are no approved drug for human adenovirus infection.This review summarized the clinical application of cidofovir in the treatment of adenovirus infection,including adult severe adenovirus infection,child adenovirus infection,organ transplantation infection,derivative compounds.In general,cidofovir has a certain role in the treatment of severe adenovirus infection,but most studies have small sample sizes and lack prospective cohort studies,which should be considered in future clinical studies.In addition,the development of derivative compounds or similar drugs based on cidofovir to reduce its renal toxicity is also the focus of future research.

关 键 词:腺病毒 感染 重症 西多福韦 核苷类似物 

分 类 号:R511.8[医药卫生—内科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象